GLP-1 agonist market in the U.S
When to stop and seek medical attention Severe persistent vomiting that prevents adequate hydration
If you have hit a plateau at the 2mg dose, do not increase your dose further
While earlier GLP-1 drugs have decades of data behind them, newer high-potency agonists and multi-agonist combinations will require extended monitoring as their use expands
Limitations of current evidence: It is important to note that most studies have been relatively short-term (12-26 weeks), with limited data on long-term reproductive outcomes, fertility, or pregnancy rates
Youll walk away with a completely new toolkit for breaking through patient resistance, dissolving medication hesitancy, and creating clinical encounters that actually inspire change!